Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG CLASS:

CD166-targeted antibody-drug conjugate

DRUG CLASS:

CD166-targeted antibody-drug conjugate

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Related drugs:

‹

›

HER2 Negative Breast Cancer

Sensitive: C3 – Early Trials

Sensitive: C3 – Early Trials